Autologous stem cell transplantation (ASCT) is a good option in fit young patients affected by POEMS syndrome. Few data are published on how to treat these patients in case of relapse. In this paper we described our two patients who underwent a second ASCT. From our experience, we can confirm that a second transplant is a real treatment option with good results and limited side effects. It provided excellent response and long-term disease-free survival in POEMS patients who relapsed after a first transplant, including late relapses.
Autore, F., Innocenti, I., Sora', F., Chiusolo, P., Piccirillo, N., Bacigalupo, A., Sica, S., Laurenti, L., Successful Second Autologous Stem Cell Transplantation for Late Disease Progression after the First Procedure in POEMS Syndrome, <<APPLIED SCIENCES>>, 2022; 12 (5): N/A-N/A. [doi:10.3390/app12052577] [https://hdl.handle.net/10807/325029]
Successful Second Autologous Stem Cell Transplantation for Late Disease Progression after the First Procedure in POEMS Syndrome
Autore, Francesco;Innocenti, Idanna;Sora', Federica;Chiusolo, Patrizia;Piccirillo, Nicola;Bacigalupo, Andrea;Sica, Simona;Laurenti, Luca
2022
Abstract
Autologous stem cell transplantation (ASCT) is a good option in fit young patients affected by POEMS syndrome. Few data are published on how to treat these patients in case of relapse. In this paper we described our two patients who underwent a second ASCT. From our experience, we can confirm that a second transplant is a real treatment option with good results and limited side effects. It provided excellent response and long-term disease-free survival in POEMS patients who relapsed after a first transplant, including late relapses.| File | Dimensione | Formato | |
|---|---|---|---|
|
applsci-12-02577.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
212.54 kB
Formato
Adobe PDF
|
212.54 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



